Aspirin-C, Brausetabletten

7680336700367 CH-33670 Brausetabletten
Aspirin-C, Brausetabletten
Aspirin-C, Brausetabletten
Aspirin-C, Brausetabletten
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
Tablette(n)
Galenic form
Brausetabletten
Galenic group
Brausetabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/11/2024
Patient information leaflet
Français
19/11/2024
Patient information leaflet
Italien
19/11/2024
Summary of Product Characteristics
Allemand
19/11/2024
Summary of Product Characteristics
Français
19/11/2024
Summary of Product Characteristics
Italien
19/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
240.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
466.0 MG Substance HBESI

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
33670
Drug name
Aspirin-C, Brausetabletten
Galenic form
BRAT
ATC Code
N02BA51
Authorization status
Z
Dispensing category
D
First authorization
05/10/1970
Authorization expiration date
31/12/9999
IT Number
01.01.2.
Domain
Human medicine
Field of application
Fieber und Schmerzen bei Erkältungskrankheiten

Package details

Description (FR)
ASPIRINE C cpr eff sach 20 pce
Description (DE)
ASPIRIN C Brausetabl Btl 20 Stk
Market launch
05/10/1970
Narcotic (BTM)
No

Other package sizes (1)

ASPIRINE C cpr eff sach 10 pce
10 TABL
GTIN: 7680336700282
View